Rchr
J-GLOBAL ID：202101016768146818   Update date: Sep. 30, 2024

Kanie Keitaro

カニエ ケイタロウ | Kanie Keitaro
Affiliation and department：
Center for iPS Cell Research and Application (CiRA), Kyoto University Department of Cell Growth and Differentiation

About Center for iPS Cell Research and Application (CiRA), Kyoto University Department of Cell Growth and Differentiation


Research field  (3)： Immunology ,  Molecular biology ,  Metabolism and endocrinology
Research theme for competitive and other funds  (3)：
  • 2021 - 2026 Elucidation of the etiology of congenital hypopituitarism and creation of new disease concepts based on pioneering analysis methods
  • 2022 - 2025 Elucidation of new pathophysiology of autoimmune pituitary diseases caused by a paraneoplastic syndrome
  • 2021 - 2023 Elucidation of the pathogenic mechanism of autoimmune pituitary diseases
Papers (27)：
  • Kohei Nagano, Yuma Motomura, Hironori Bando, Masaaki Yamamoto, Keitaro Kanie, Kei Yoshino, Yushi Hirota, Tomoko Yamada, Michiko Takahashi, Hidenori Fukuoka, et al. Thyroid dysfunction due to trace element deficiency-not only selenium but also zinc. Hormones (Athens, Greece). 2024
  • Maki Kanzawa, Hiroki Shichi, Keitaro Kanie, Masaaki Yamamoto, Naoki Yamamoto, Yasutaka Tsujimoto, Hironori Bando, Genzo Iguchi, Shigehisa Kitano, Naoko Inoshita, et al. Effects of the cortisol milieu on tumor-infiltrating immune cells (TIICs) in corticotroph tumors. Endocrinology. 2024
  • Yuka Ohmachi, Masaaki Yamamoto, Yuiko Inaba, Shohei Makino, Shin Urai, Risa Matsumoto, Hironori Bando, Keitaro Kanie, Yasutaka Tsujimoto, Yuma Motomura, et al. The combination of doxazosin and metyrosine as a preoperative treatment for pheochromocytomas and paragangliomas. Endocrine. 2024
  • Shin Urai, Genzo Iguchi, Keitaro Kanie, Hironori Bando, Masaaki Yamamoto, Yuka Oi, Yuya Kashitani, Keiji Iida, Maki Kanzawa, Hidenori Fukuoka, et al. Clinical features of anti-PIT-1 hypophysitis: A new aspect of paraneoplastic autoimmune condition. European journal of endocrinology. 2023
  • Shin Urai, Masaaki Yamamoto, Naoki Yamamoto, Masaki Suzuki, Hiroki Shichi, Keitaro Kanie, Yasunori Fujita, Hironori Bando, Hidenori Fukuoka, Michiko Takahashi, et al. Newer parameters of the octreotide test in patients with acromegaly. Pituitary. 2023
ｍore...
MISC (138)：
  • 合田 菜穂, 神澤 真紀, 辻本 泰貴, 蟹江 慶太郎, 山本 雅昭, 臼井 健, 高橋 裕, 小川 渉, 福岡 秀規. BMHAにおけるアルドステロン自律性分泌とその病理学的検討. 日本内分泌学会雑誌. 2024. 99. 5. 1681-1681
  • 蟹江慶太郎, 金子新, 金子新. ex vivo gene editing-HLA editing for regenerative immunotherapy. 実験医学. 2024. 42. 6
  • 神澤真紀, 志智大成, 蟹江慶太郎, 山本雅昭, 山本直希, 辻本泰貴, 坂東弘教, 井口元三, 北野滋久, 井下尚子, et al. コルチゾール暴露環境がコルチコトロフ腫瘍における免疫細胞浸潤に与える影響. 間脳・下垂体・副腎系研究会プログラム・抄録集(Web). 2024. 35th
  • 浦井 伸, 蟹江 慶太郎, 坂東 弘教, 山本 雅昭, 大井 佑夏, 樫谷 悠也, 飯田 啓二, 神澤 真紀, 福岡 秀規, 井口 元三, et al. 抗PIT-1下垂体炎新規2例を加えた9症例の臨床的特徴. 日本内分泌学会雑誌. 2023. 99. 1. 311-311
  • 浦井 伸, 蟹江 慶太郎, 坂東 弘教, 山本 雅昭, 大井 佑夏, 樫谷 悠也, 飯田 啓二, 神澤 真紀, 福岡 秀規, 井口 元三, et al. 抗PIT-1下垂体炎新規2例を加えた9症例の臨床的特徴. 日本内分泌学会雑誌. 2023. 99. 1. 311-311
ｍore...
Lectures and oral presentations  (17)：
  • 抗PIT-1下垂体炎新規2例を加えた9症例の臨床的特徴
    (日本内分泌学会雑誌 2023)
  • 疾患iPS細胞を用いた自己免疫性下垂体疾患のin vitro疾患モデル樹立と進展防止のための創薬への応用
    (第22回日本再生医療学会総会 2023)
  • 免疫チェックポイント阻害薬関連下垂体炎の新たな病態
    (第32回臨床内分泌代謝Update 2022)
  • 疾患iPS細胞を用いた自己免疫性下垂体疾患の in vitro疾患モデルの樹立
    (第95回日本内分泌学会学術総会 2022)
  • 疾患iPS細胞を用いた 自己免疫性下垂体疾患のin vitro疾患モデル樹立と 進展防止のための創薬への応用
    (第95回日本内分泌学会学術総会 2022)
ｍore...
Education (2)：
  • 2017 - 2021 Kobe University Graduate School of Medicine
  • 2005 - 2011 The University of Tokushima Faculty of Medicine School of Medicine
Professional career (1)：
  • Doctor of Medicine (Kobe University Graduate School of Medicine)
Work history (3)：
  • 2022/04 - 現在 Kobe University Graduate school of medicine Division of Diabetes and Endcrinology
  • 2022/04 - 現在 Kyoto University
  • 2021/04 - 2022/03 神戸大学医学部附属病院 糖尿病・内分泌内科 医員
Awards (3)：
  • 2022/06 - Japan Endocrine Society Young Investigator Award
  • 2020/11 - The Japan Endocrine Society Excellent poster award
  • 2019/05 - The Japan Endocrine Society Knockout Round high score presentation award Modeling Anti-PIT-1 Syndrome In Vitro Using Human Induced Pluripotent Stem Cells
Association Membership(s) (6)：
The Japanese Cancer Association ,  The Japanese Society for Regenerative Medicine ,  The Japanese Society for Hypothalamic and Pituitary tumors ,  Japan Endocrine Society ,  The Japanese Society of Internal Medicine ,  The Japan Diabetes Society
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM